ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726442 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726442; 2) Community: the network communities that were significantly associated with the response to NSC 726442; 3) Molecule: the relationships between components within communities and NSC 726442; 4) MDR: the compounds that were significantly associated with the NSC 726442.

NSC Compound Enrichment Correlation
NSC 329277 Null 0.0237269271456697 0.073279947
NSC 664701 Null 0.0237269271456697 0.34938885
NSC 668485 Null 0.0237269271456697 0.40633543
NSC 711077 Null 0.0237269271456697 0.36890083
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0237269271456697 0.15615481
NSC 726217 Combretastatin A4-analogue 0.0237269271456697 0.4832055
NSC 733476 Null 0.0237269271456697 0.27156146
NSC 744023 (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0237269271456697 0.27290637
NSC 751042 Null 0.0237269271456697 0.27084533
NSC 727286 6-(bromomethyl)-1,4-anthracenedione. 0.0291420747327558 0.15377756
Total:48  Current:27    [First] [Prev] [Next] [Last]